Bixiye
2020 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Natiijooyinka Raadinta
Soo bandhiga 1591 - 1600 ee natiijooyinka 4163
Bixiye
QP34-20 New Claims Status Online Messaging Available on Availity
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP33-20 Updates to Telemedicine/Telehealth and Telephone Call Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP28-20 Updated Service Type Options for Surgery on Availity Portal
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP29-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Peanut Allergy
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP30-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
2020 March Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: 24, Feb 2020
Bixiye
QP8-20 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP25-20 Pharmacy Benefit Exclusion for Injectafer®, Feraheme®, Venofer®, INFeD®, Ferrlecit®, and generic Ferrlecit®
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020